What is the sales limit of pseudoephedrine within a 30-day period?

The sales limit of pseudoephedrine within a 30-day period is set at a maximum of 7,500 milligrams. This regulation is primarily aimed at controlling the potential misuse of pseudoephedrine, which can be used to synthesize methamphetamine. By imposing this limit, regulatory agencies can mitigate the risks associated with the over-purchase of this substance, ensuring that it is used appropriately for legitimate medical purposes while preventing its diversion for illicit use.

Other options, such as lower limits like 1,500 milligrams or 5,000 milligrams, do not align with the federal guidelines and state regulations that aim to balance accessibility for therapeutic needs with necessary restrictions to prevent abuse. A limit of no sales, or "no limit," fails to address the public health issues associated with its potential for misuse. Therefore, the established limit reflects both a regulatory approach to pharmacy practice and a public safety measure.